淋巴血管侵犯
腺癌
阶段(地层学)
医学
内科学
病态的
肺
胃肠病学
T级
肿瘤科
肺癌
病理
总体生存率
癌症
转移
生物
古生物学
作者
Hiroe Itami,Takeshi Kawaguchi,Daiki Yoshikawa,Takashi Watanabe,Chiyoko Terada,Fumi Okada,Tomoko Uchiyama,Maiko Takeda,Eiwa Ishida,Yuko Nishimoto,Hiroshi Okada,Keiji Kushibe,Noriyoshi Sawabata,Chiho Ohbayashi
标识
DOI:10.1136/jclinpath-2021-208053
摘要
Although it is necessary to measure the invasive size of lung adenocarcinoma with a lepidic component, it is not uncommon to have trouble in measuring the invasive size of lung adenocarcinoma. This study examined whether there were other stronger prognostic factors than invasive size.We characterised the clinicopathological features associated with recurrence-free survival (RFS) of 686 patients with the pathological stage (p-Stage) I lung adenocarcinoma. Moreover, we compared the area under the curve (AUC) values for recurrence between various combinations of pathological-baseline (age & sex & p-Stage based on invasive size) (B(i)) and several prognostic factors, and various combinations of p-baseline based on total tumour size (B(t)) and several prognostic factors.AUC showed no significant differences between B(i) & new International Association for the Study of Lung Cancer grade (G) or vascular invasion (V), and B(t) & G or V. AUC was the highest in B & G & lymphatic invasion (L) & V. RFS was significantly shorter in patients with G3 OR L(+) OR V(+) than in those with G≤2 AND L(-) AND V(-) in each p-Stage based on invasive size (p-Stage(i)) and p-Stage based on total tumour size (p-Stage(t)) (p<0.05), and there were no significant differences in RFS between each p-Stage(i) and p-Stage(t).In any invasive size or total tumour size of p-Stage I lung adenocarcinoma, G, L and V are more powerful prognostic factors than the size criteria of p-Stage. Therefore, pathologists should focus on these pathological findings.
科研通智能强力驱动
Strongly Powered by AbleSci AI